Optiscan Imaging Ltd
  • Home
  • About Us
    • Who We Are
    • Purpose & Values
    • Board
    • Partners
    • Distributors
    • Compliance
    • Careers
  • Technology
    • Our Solution
    • Technology Introduction
    • Platform Technology
    • Publications
    • Image Gallery
    • Webinars
    • FAQ
  • Products
    • Our Products
    • InVivage
    • ViewnVivo
    • Customisation
  • Pipeline
  • Investor
    • Investor Overview
    • ASX Announcements
    • Reports
    • Share Price Information
    • Financial Calendar
    • Media Coverage
    • Sustainability
    • Share Registry
    • Investor Alerts
  • Media
    • News
    • Social Media Feed
  • Contact
    • Contact

Sub-heading can be edited through HQI

Home > Media > News
    • News
    • Social Media Feed

Recent Posts

  • Optiscan completes ANDHealth Activate Program
  • Tech Operating at Sharp End of Surgery (The Australian)
  • Optiscan’s Platform could address Global Pathologist Shortage
  • ‘Diagnose on the spot’: Optiscan’s Platform brings together Surgeons and Pathologists for Better Cancer Outcomes
  • Optiscan Moves to Stamp Stronger US Footprint

Archives

  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • November 2022
  • September 2022
  • February 2022
  • May 2021
  • March 2021
  • January 2021
  • December 2020

Categories

  • Announcements
  • Blood vessel, perfusion, and barrier function
  • Brain cancer
  • Broker Research
  • Cell viability
  • Cervical assessment
  • Gastrointestinal assessment
  • General surgery
  • Intraoperative surgery and tumour margin delineation
  • Live antibody labelling
  • Live microflora imaging
  • Nano particle and drug delivery
  • Optiscan news
  • Oral cancer diagnosis and surgical margin
  • Proof of concept in live models
  • Uncategorized
  • Veterinary

Dr. Camile Farah talks with Matt Birney on 2GB Sydney Radio

Posted on February 6th, 2023. by Andrew Barker

cf radio Sydney

We are pleased to advise our CEO Dr. Camile Farah spoke with Matt Birney on 2GB Sydney today, providing an update on our recent AI partnership with Prolucid Technologies.

To listen click here

Posted in Uncategorized

Select Category

  • Optiscan news
  • Partner news
  • Media

Quick Links

Contact Us

Optiscan Imaging Ltd
16 Miles Street, Mulgrave
Melbourne VIC 3170
AUSTRALIA

T: +61 (3) 9538 3333
E: info@optiscan.com

Optiscan Imaging Ltd
16 Miles Street, Mulgrave
Melbourne VIC 3170
AUSTRALIA

T: +61 (3) 9538 3333
E: info@optiscan.com

Stay Connected

Register Your Interest

Subscribe to Investor Alerts

Stay in Touch

Which of the following group do you best fit?

 

Email Alerts

Subscribe to Email Alerts

Follow Us

Copyright © Optiscan Imaging Ltd
Site Map Search Terms of Use Privacy Policy Cookies Policy
Site by